Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



HANNAH ALISON L. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns: Granted 8,353 options to buy @ $14.82, valued at $123.8k
Granted 11,336 restricted stock units @ $0
07/12/2023 4 HANNAH ALISON L. (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 25,000 shares @ $0
Granted 30,000 options to buy @ $1.32, valued at $39.6k
07/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 HANNAH ALISON L. (Chief Medical Officer) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 22,500 shares @ $0
Granted 135,000 options to buy @ $4.13, valued at $557.6k
10/26/2021 4 HANNAH ALISON L. (Chief Medical Officer) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $5.34, valued at $213.6k
Granted 30,000 options to buy @ $0
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2020 4 HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns: Granted 2,698 shares @ $0
Granted 3,448 options to buy @ $28.54, valued at $98.4k
02/05/2020 4 HANNAH ALISON L. (Chief Medical Officer) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 250,000 options to buy @ $7.71, valued at $1.9M
02/05/2020 3 HANNAH ALISON L. (Chief Medical Officer) has filed a Form 3 on CytomX Therapeutics, Inc.
09/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2019 4 HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns: Granted 3,419 shares @ $0
Granted 4,269 options to buy @ $22.52, valued at $96.1k
06/05/2018 4 HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns: Granted 15,564 shares @ $0
Granted 3,017 options to buy @ $11.6, valued at $35k
10/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
08/01/2016 4 HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns: Granted 5,072 restricted stock units @ $0
Granted 8,333 options to buy @ $9.11, valued at $75.9k
05/04/2016 4 HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns: Granted 2,150 shares @ $7.15, valued at $15.4k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy